This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

LabCorp Announces Changes To Board Of Directors

Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) today announced that Drs. Arthur H. Rubenstein and M. Keith Weikel will retire from the Board at the conclusion of their current term on May 14, 2014 pursuant to the Board’s mandatory retirement policy and Wendy E. Lane has also informed the Board of Directors of her decision to retire from the Board at that time. The Company also announced that D. Gary Gilliland, M.D., Ph.D. has been appointed to its Board of Directors, effective April 1, 2014.

Drs. Rubenstein and Weikel will retire from the Board pursuant to the Company’s mandatory retirement policy which provides that when a director reaches the age of 75 he or she shall not be eligible to stand for re-election at the next regularly scheduled annual shareholder meeting. In addition, Ms. Lane has informed the Board that she has decided not to stand for re-election to the Board of Directors to pursue other professional interests, including other board opportunities.

Dr. Rubenstein has served as a Director of LabCorp since 2004, serving as Chair of the Quality and Compliance Committee since 2008. Dr. Weikel has served as a Director of LabCorp since 2003 and as Chair of the Compensation Committee since 2008. Ms. Lane has served as Director of LabCorp since 1996, serving on the Compensation, Audit and Nominating and Corporate Governance Committees. She served as the Chair of the Audit Committee from 2003 to 2008.

“Arthur, Keith and Wendy have been exceptional Board members and have made tremendous contributions to LabCorp during their years of service,” said David P. King, Chairman and Chief Executive Officer. “Each has served with distinction, both as a Board member and as Chair of an important Board Committee. On behalf of the Board and LabCorp, I wish to express our gratitude for their invaluable leadership and years of dedicated service to the Company. At the same time we are committed to Board renewal and succession planning, and these changes reflect that ongoing process.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs